These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11699223)

  • 1. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long- term survival.
    Giles FJ; Shen Y; Kantarjian HM; Korbling MJ; O'Brien S; Anderlini P; Donato M; Pierce S; Keating MJ; Freireich EJ; Estey E
    Leuk Lymphoma; 2001 Jun; 42(1-2):67-73. PubMed ID: 11699223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
    Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
    Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
    Malkan UY; Ozcebe OI
    Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
    Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial respiratory status in hyperleukocytic acute myeloid leukemia: prognostic significance and effect of leukapheresis.
    Van de Louw A; Schneider CW; Desai RJ; Claxton DF
    Leuk Lymphoma; 2016; 57(6):1319-26. PubMed ID: 26374497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
    Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
    Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
    Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
    Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
    Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
    Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous-flow leukapheresis for rapid cytoreduction in leukemia.
    Lane TA
    Transfusion; 1980; 20(4):455-7. PubMed ID: 6931450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate.
    Porcu P; Danielson CF; Orazi A; Heerema NA; Gabig TG; McCarthy LJ
    Br J Haematol; 1997 Aug; 98(2):433-6. PubMed ID: 9266944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage.
    Chang MC; Chen TY; Tang JL; Lan YJ; Chao TY; Chiu CF; Ho HT
    Am J Hematol; 2007 Nov; 82(11):976-80. PubMed ID: 17636473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
    Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
    Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
    Villgran V; Agha M; Raptis A; Hou JZ; Farah R; Lim SH; Redner RL; Im A; Sehgal A; Dorritie KA; Kiss JE; Normolle D; Boyiadzis M
    Transfus Apher Sci; 2016 Oct; 55(2):216-220. PubMed ID: 27470709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
    De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
    J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
    Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
    J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
    Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
    Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
    Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
    Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia.
    Veljković D; Kuzmanović M; Mićić D; Šerbić-Nonković O
    Transfus Apher Sci; 2012 Jun; 46(3):263-7. PubMed ID: 22480956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
    Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
    Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/µl.
    Chen W; Rizzieri D; Drago S
    J Clin Apher; 2015 Feb; 30(1):28-31. PubMed ID: 24975628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.